CGT Global Blog
CGT Global News
Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.
LUPUS PATIENTS NEEDED
We are working to provide researchers with the Lupus samples they need to help accelerate medical research for new treatment technologies and cures. If you have lupus and want to know more about donating, please click here to sign up for a phone screening. If someone you know has lupus and may be interested in participating, please share this information. If you are eligible to donate blood, you will be compensated $50 for your time and effort. If you don’t have Lupus but…
Read MoreBlood Biopsies as a Source to Determine Treatment Options for Metastatic Tumors
Cancer arises due to the accumulation of alterations in genes that control cell survival, growth, proliferation, and differentiation, which provides a distinct genetic profile of the cancer. This genetic profile is typically assessed using DNA and/or RNA obtained from a biopsy of the primary tumor and aids in providing a therapeutic strategy for dealing with the tumor. However, genomic instability and the ability to evolve to various interactions with microenvironmental cues, including therapeutic drugs, is a hallmark of cancer. Constant and unchecked…
Read MoreExploring the Potential of lncRNAs as Biomarkers for Rheumatoid Arthritis
Long noncoding RNAs, also known as lncRNAs, are a large and diverse class of transcribed RNA molecules that are longer than 200 nucleotides and do not code for proteins. Currently, around 35,000 lncRNAs exist in the human genome and are part of the regulatory class of RNAs. Some of these lncRNAs have been fully characterized and take part in gene inhibition or gene activation in mechanisms relating to chromatin modification and structure, direct transcriptional regulation, RNA processing events, protein activity and localization,…
Read MoreRunning for health and to support local charities!
Way to go StemExpressers! Running for health and to benefit local charities in Sacramento at the California International Marathon. What an inspiration to see so many people out running and so many awesome supporters cheering everyone on! [layerslider id=”113″] embed code youtube .newst{position:relative;text-align:right;height:420px;width:520px;} #gmap_canvas img{max-width:none!important;background:none!important}
Read MoreCANCER PATIENTS HELP RESEARCHERS BY DONATING BLOOD
The StemExpress Foundation is in need of cancer patients, and other with diseases, to donate blood for research. Read the inspirational story of Meagan Shull, a cancer survivor, and her experience donating to the StemExpress Foundation. You can find the article below, or download the full PDF here. Interested in donating blood? Learn more here.
Read MoreThe Role of CD56 During Invasive Aspergillosis
Aspergillus (A.) fumigatus is a species of mold that is found ubiquitously in nature and the inhalation of its spores by healthy adults is a common occurrence having a relatively harmless effect. However, for immunosuppressed patients suffering from hematological malignancies or undergoing hematopoietic stem cell or solid organ transplantation, this species of mold is responsible for invasive aspergillosis (IA), an infection that spreads to the blood vessels and into organs. Prognosis for IA is poor, with a mortality rate ranging from 60-90%…
Read MoreSACRAMENTO BUSINESS JOURNAL INTERVIEW WITH CATE DYER
Cate Dyer CEO & Founder of StemExpress A local journalist talks with StemExpress CEO, Cate Dyer, about the importance of her company’s mission to accelerate research and what that means for the future of patient care and the development of new treatments. Read the Article
Read MoreRegenerative Medicine – Overcoming Regulatory Barriers
Regulatory barriers often inhibit the timely delivery of cutting-edge cellular therapeutics to patients burdened with chronic diseases and disabilities. The Bipartisan Policy Center and Regenerative Medicine Foundation are trying to change this by recommending that Congress support a federally funded registry for regenerative cell therapies. This registry would help share the outcomes of potentially curative therapies so that the general public, clinicians, and researchers are able to learn from shared data. This would help inform decision-making and ultimately help accelerate the development…
Read MoreLIGHT THE NIGHT 2017
Thank you to everyone who participated in the Leukemia and Lymphoma Society’s Light the Night Walk in! Thousands of people came out on Saturday night to support, celebrate, and remember those affected by blood cancer in the Sacramento area. We hope you grabbed a StemExpress water bottle by the Orchard gate and said hi if you were there embed code youtube .newst{position:relative;text-align:right;height:420px;width:520px;} #gmap_canvas img{max-width:none!important;background:none!important} Each registered walker at the Light the Night event received a lantern to carry with them on their…
Read MoreLUNG CANCER PROJECT
The ever-present goal of the StemExpress Foundation is to improve the lives and outcomes of patients with all kinds of diseases. To that end, we are excited to be participating in a new lung cancer project! Researchers have created a new diagnostic tool to detect lung cancer earlier and in a less invasive way than traditional biopsies. In order to make this new screening available to the public, these scientists need small samples of blood from people with lung cancer so that…
Read MoreSHARE YOUR STORY
What do you wish people knew about your condition? Illness and disease affect our lives in so many different ways, and no two experiences are the same. You could write about how you or a loved one has been affected by disease, why you chose to participate in medical research, or what you hope will be cured in the future. If you want to share your story with us, but do not want it published on the StemExpress Foundation Blog, just let…
Read More